Pharmaceutical CRDMO Service - Global and China Top Players Market Share and Ranking 2023
Report Code: KNJ1623518 No. of Pages: 149 Category: Services
Publisher: Date of Publish:
Publisher: Date of Publish:
According to YH Research, the global market for Pharmaceutical CRDMO Service should grow from US$ 83 million in 2022 to US$ 130.6 million by 2029, with a CAGR of 6.8% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Pharmaceutical CRDMO Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Pharmaceutical CRDMO Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Oncology grew percent to account for percent of the total market sales, and Infectious Disease grew percent.
This report studies and analyses global Pharmaceutical CRDMO Service status and future trends, to help determine the Pharmaceutical CRDMO Service market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical CRDMO Service, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pharmaceutical CRDMO Service market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Pharmaceutical CRDMO Service by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Pharmaceutical CRDMO Service by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Pharmaceutical CRDMO Service key consuming regions, consumption value and demand structure
(5) Pharmaceutical CRDMO Service industry chains, upstream, midstream and downstream
Market segment by players, this report covers
BioDuro-Sundia
Sai Life Sciences
Icosagen
WuXi Biologics
WuXi AppTec
Esco Aster
Jubilant Biosys
Syngene International
Chemveda
Ardena Holding
Eurofins
Jiangsu HUAYI Technology Co., Ltd.
Market segment by Type, covers
Small Molecule CRDMO Service
Middle Molecule CRDMO Service
Large Molecule CRDMO Service
Market segment by Application, can be divided into
Oncology
Infectious Disease
Neurology
Immunology
Hematology
Vaccine
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pharmaceutical CRDMO Service product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pharmaceutical CRDMO Service market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Pharmaceutical CRDMO Service market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Pharmaceutical CRDMO Service industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Pharmaceutical CRDMO Service Definition
1.2 Global Pharmaceutical CRDMO Service Market Size and Forecast
1.3 China Pharmaceutical CRDMO Service Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Pharmaceutical CRDMO Service Market Size: China VS Global Growth Rate, 2018-2029
1.6 Pharmaceutical CRDMO Service Market Dynamics
1.6.1 Pharmaceutical CRDMO Service Market Drivers
1.6.2 Pharmaceutical CRDMO Service Market Restraints
1.6.3 Pharmaceutical CRDMO Service Industry Trends
1.6.4 Pharmaceutical CRDMO Service Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Pharmaceutical CRDMO Service, Global Market Share by Company, 2018-2023
2.2 Global Pharmaceutical CRDMO Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Pharmaceutical CRDMO Service Concentration Ratio
2.4 Global Pharmaceutical CRDMO Service Mergers & Acquisitions, Expansion Plans
2.5 Global Pharmaceutical CRDMO Service Major Companies Product Type
2.6 Head Office and Pharmaceutical CRDMO Service Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Pharmaceutical CRDMO Service, China Market Share by Company, 2018-2023
3.2 China Pharmaceutical CRDMO Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Pharmaceutical CRDMO Service Industry Chain
4.2 Pharmaceutical CRDMO Service Upstream Analysis
4.2.1 Pharmaceutical CRDMO Service Core Raw Materials
4.2.2 Main Manufacturers of Pharmaceutical CRDMO Service Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Pharmaceutical CRDMO Service Production Mode
4.6 Pharmaceutical CRDMO Service Procurement Model
4.7 Pharmaceutical CRDMO Service Industry Sales Model and Sales Channels
4.7.1 Pharmaceutical CRDMO Service Sales Model
4.7.2 Pharmaceutical CRDMO Service Typical Distributors
5 Sights by Type
5.1 Pharmaceutical CRDMO Service Classification
5.1.1 Small Molecule CRDMO Service
5.1.2 Middle Molecule CRDMO Service
5.1.3 Large Molecule CRDMO Service
5.2 By Type, Global Pharmaceutical CRDMO Service Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Pharmaceutical CRDMO Service Consumption Value, 2018-2029
6 Sights by Application
6.1 Pharmaceutical CRDMO Service Segment by Application
6.1.1 Oncology
6.1.2 Infectious Disease
6.1.3 Neurology
6.1.4 Immunology
6.1.5 Hematology
6.1.6 Vaccine
6.1.7 Others
6.2 By Application, Global Pharmaceutical CRDMO Service Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Pharmaceutical CRDMO Service Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Pharmaceutical CRDMO Service Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Pharmaceutical CRDMO Service Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Pharmaceutical CRDMO Service & Forecasts, 2018-2029
7.3.2 By Country, North America Pharmaceutical CRDMO Service Market Size Market Share
7.4 Europe
7.4.1 Europe Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Pharmaceutical CRDMO Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Pharmaceutical CRDMO Service Market Size Market Share
7.6 South America
7.6.1 South America Pharmaceutical CRDMO Service Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Pharmaceutical CRDMO Service Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Pharmaceutical CRDMO Service Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Pharmaceutical CRDMO Service Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Pharmaceutical CRDMO Service Market Size, 2018-2029
8.3.2 By Type, U.S. Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Pharmaceutical CRDMO Service Market Size, 2018-2029
8.4.2 By Type, Europe Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Pharmaceutical CRDMO Service Market Size, 2018-2029
8.5.2 By Type, China Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Pharmaceutical CRDMO Service Market Size, 2018-2029
8.6.2 By Type, Japan Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Pharmaceutical CRDMO Service Market Size, 2018-2029
8.7.2 By Type, South Korea Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Pharmaceutical CRDMO Service Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Pharmaceutical CRDMO Service Market Size, 2018-2029
8.9.2 By Type, India Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Pharmaceutical CRDMO Service Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Pharmaceutical CRDMO Service Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 BioDuro-Sundia
9.1.1 BioDuro-Sundia Company Information, Head Office, Market Area and Industry Position
9.1.2 BioDuro-Sundia Company Profile and Main Business
9.1.3 BioDuro-Sundia Pharmaceutical CRDMO Service Models, Specifications and Application
9.1.4 BioDuro-Sundia Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.1.5 BioDuro-Sundia Recent Developments
9.2 Sai Life Sciences
9.2.1 Sai Life Sciences Company Information, Head Office, Market Area and Industry Position
9.2.2 Sai Life Sciences Company Profile and Main Business
9.2.3 Sai Life Sciences Pharmaceutical CRDMO Service Models, Specifications and Application
9.2.4 Sai Life Sciences Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.2.5 Sai Life Sciences Recent Developments
9.3 Icosagen
9.3.1 Icosagen Company Information, Head Office, Market Area and Industry Position
9.3.2 Icosagen Company Profile and Main Business
9.3.3 Icosagen Pharmaceutical CRDMO Service Models, Specifications and Application
9.3.4 Icosagen Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.3.5 Icosagen Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Company Information, Head Office, Market Area and Industry Position
9.4.2 WuXi Biologics Company Profile and Main Business
9.4.3 WuXi Biologics Pharmaceutical CRDMO Service Models, Specifications and Application
9.4.4 WuXi Biologics Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.4.5 WuXi Biologics Recent Developments
9.5 WuXi AppTec
9.5.1 WuXi AppTec Company Information, Head Office, Market Area and Industry Position
9.5.2 WuXi AppTec Company Profile and Main Business
9.5.3 WuXi AppTec Pharmaceutical CRDMO Service Models, Specifications and Application
9.5.4 WuXi AppTec Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.5.5 WuXi AppTec Recent Developments
9.6 Esco Aster
9.6.1 Esco Aster Company Information, Head Office, Market Area and Industry Position
9.6.2 Esco Aster Company Profile and Main Business
9.6.3 Esco Aster Pharmaceutical CRDMO Service Models, Specifications and Application
9.6.4 Esco Aster Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.6.5 Esco Aster Recent Developments
9.7 Jubilant Biosys
9.7.1 Jubilant Biosys Company Information, Head Office, Market Area and Industry Position
9.7.2 Jubilant Biosys Company Profile and Main Business
9.7.3 Jubilant Biosys Pharmaceutical CRDMO Service Models, Specifications and Application
9.7.4 Jubilant Biosys Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.7.5 Jubilant Biosys Recent Developments
9.8 Syngene International
9.8.1 Syngene International Company Information, Head Office, Market Area and Industry Position
9.8.2 Syngene International Company Profile and Main Business
9.8.3 Syngene International Pharmaceutical CRDMO Service Models, Specifications and Application
9.8.4 Syngene International Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.8.5 Syngene International Recent Developments
9.9 Chemveda
9.9.1 Chemveda Company Information, Head Office, Market Area and Industry Position
9.9.2 Chemveda Company Profile and Main Business
9.9.3 Chemveda Pharmaceutical CRDMO Service Models, Specifications and Application
9.9.4 Chemveda Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.9.5 Chemveda Recent Developments
9.10 Ardena Holding
9.10.1 Ardena Holding Company Information, Head Office, Market Area and Industry Position
9.10.2 Ardena Holding Company Profile and Main Business
9.10.3 Ardena Holding Pharmaceutical CRDMO Service Models, Specifications and Application
9.10.4 Ardena Holding Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.10.5 Ardena Holding Recent Developments
9.11 Eurofins
9.11.1 Eurofins Company Information, Head Office, Market Area and Industry Position
9.11.2 Eurofins Company Profile and Main Business
9.11.3 Eurofins Pharmaceutical CRDMO Service Models, Specifications and Application
9.11.4 Eurofins Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.11.5 Eurofins Recent Developments
9.12 Jiangsu HUAYI Technology Co., Ltd.
9.12.1 Jiangsu HUAYI Technology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.12.2 Jiangsu HUAYI Technology Co., Ltd. Company Profile and Main Business
9.12.3 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Models, Specifications and Application
9.12.4 Jiangsu HUAYI Technology Co., Ltd. Pharmaceutical CRDMO Service Revenue and Gross Margin, 2018-2023
9.12.5 Jiangsu HUAYI Technology Co., Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com